News
Type 2 diabetes may double risk of sepsis, study suggests
Living with type 2 diabetes may double the risk of developing sepsis, especially those aged younger than 60 years and men, according to a long-term community-based study in Australia. This research wa...
Gestational diabetes linked to cognitive decline in mothers and neurodevelopmental disorders among children
A new synthesis of global evidence finds that experiencing gestational diabetes during pregnancy is linked with a decline in intellectual function among mothers, and may increase the risk of autism sp...
Tirzepatide helps weight loss among people with type 1 diabetes, research shows
In adults with type 1 diabetes and obesity, low dose tirzepatide reduced their weight, HbA1c levels and insulin dose requirements, a clinical trial has demonstrated. Presented at this year’s EASD meet...
Researchers urged to warn about women with type 2 diabetes taking oral HRT
In women with type 2 diabetes, use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke. However, an increased cardiovascular risk was found ...
Spirit Health launches CareSens Air CGM giveaway for World Diabetes Day
As part of its ongoing commitment to improving access to innovative diabetes technology, Spirit Health has announced a CareSens Air Continuous Glucose Monitor (CGM) giveaway for healthcare professiona...
Smoking increases the risk of type 2 diabetes, evidence reveals
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) 2025 in Vienna shows that smoking increases the risk of type 2 diabetes, regardless of subtype...
Links between diabetes and depression are similar across Europe, study finds
The relative increase in odds of an individual with diabetes developing severe symptoms of depression – and vice versa – is the same, regardless of where they live. This is according to a study of ove...
CagriSema provides ‘substantial’ body weight reductions, research reports
An international type 2 diabetes expert presented the latest findings from the REDEFINE 2 study at the prestigious European Association for the Study of Diabetes (EASD) 2025 meeting. Professor Melanie...
Half of people stop taking popular weight-loss drug within a year, national study finds
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study pres...